Genome-wide association studies (GWAS) for atrial fibrillation (AF) have identified three
distinct genetic loci on chromosomes 1q21, 4q25, and 16q22 that are associated with the …

Atrial fibrillation (AF) is the most common cardiac arrhythmia with well-established clinical
and genetic risk components. Genome-wide association studies (GWAS) have identified 17 …

Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased
morbidity. As the population ages and the prevalence of AF continues to rise, the …

New Genetic Loci for Atrial Fibrillation. Over the past decade, compelling evidence has
emerged from population‐based studies to suggest that AF is a heritable disease. More …

Atrial fibrillation (AF) affects more than 33 million individuals worldwide and has a complex
heritability. We conducted the largest meta-analysis of genome-wide association studies …

Atrial fibrillation is a highly prevalent arrhythmia and a major risk factor for stroke, heart
failure and death. We conducted a genome-wide association study (GWAS) in individuals of …

Atrial fibrillation (AF) is a prevalent arrhythmia associated with substantial morbidity,
mortality and costs. Available management strategies generally have limited efficacy and …

Atrial fibrillation is a common heart rhythm disorder that leads to an increased risk for stroke
and heart failure. Atrial fibrillation is a complex disease with both environmental and genetic …

Atrial fibrillation (AF) affects more than 5 million people worldwide; however, none of the anti-
arrhythmic drugs available now are entirely optimal in terms of efficacy and safety. A better …

Background Atrial fibrillation (AF) affects millions of individuals worldwide. The genome-
wide association studies have identified robust genetic associations with AF. Methods We …